WORLD COURIER MANAGEMENT LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

Grant Thornton UK LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The directors have assessed going concern for the company and wider global group for at least 12 months from the date of signing of the financial statements and have prepared the accounts on a going concern basis. The directors have assessed in the company and the group to which the entity belongs the effects of the global market for speciality pharmaceutical logistics as well as competition, price, tariffs, and cost inflation and related factors on both the business globally and any specific factors relating to the company as well as geo-political factors impacting the global logistics environment in the current and upcoming financial year as part of the budgeting and forecasting process.”

Group structure

1. WORLD COURIER MANAGEMENT LIMITED · parent
   1. World Courier Greece Limited 88.3% · Greece
   2. AB Global Pharma GmbH 25.5% · Germany
   3. World Courier Lithuania UAB 100% · Lithuania
   4. World Courier Sweden AB 100% · Sweden
   5. World Courier Denmark A/S 100% · Denmark
   6. World Courier Finland Oy 100% · Finland
   7. World Courier Norway AS 100% · Norway
   8. World Courier New Zealand Limited 100% · New Zealand
   9. World Courier Singapore Pte Limited 100% · Singapore
   10. World Courier Kenya 100% · Kenya

Significant events

• “During the year, the company transferred its entire interest in Aerolink GmbH to AB Global Pharma GmBH a group company. The disposal resulted in consideration of £23.8 million and a gain on disposal of £22.3 million, which has been recognized in the company's statement of profit or loss.”
• “On 09 September 2025, the company invested £23.8 million in AB Global Pharma GmbH, a company incorporated in Germany as consideration for the transfer of Aerolink GmbH.”
• “The company declared and paid dividends of £180m on 19 November 2025.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

4

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  -6.8%

  £440,777,741 → £410,899,722

• Cash

  -84.7%

  £65,832,932 → £10,086,705

• Net assets

  -16.2%

  £358,071,722 → £300,222,907

• Employees

  -5.1%

  98 → 93

• Operating profit

  -20.1%

  £96,711,280 → £77,262,207

• Profit before tax

  -18.4%

  £103,818,572 → £84,701,126

• Wages

  -4.3%

  £9,548,653 → £9,139,835

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers